| NCT Number | NCT06459024 |
| Lead Sponsor | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Collaborators: Hospital Vall d'Hebron, Cyprus Institute of Neurology and Genetics, European LeukemiaNet, Fundacion Para La Investigacion Hospital La Fe, Ostedusche Hematology and Oncology Study Group, Ospedale Pediatrico Bambin Gesù, Czech Lymphoma Study Group, Charite University, Berlin, Germany, Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León, University of Bologna, Hannover Medical School, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Toscana Life Sciences Sviluppo s.r.l., Lithuanian University of Health Sciences, Gruppo Italiano Malattie EMatologiche dell'Adulto, Time.Lex |
| Conditions | Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory |
| Enrollment | 4,000 participants |
| Start Date | 2024-06-28 |
| Primary Completion | 2032-07 (estimated) |
| Study Completion | 2032-07 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-14 |